CIMZIA
Google image searchProduct monograph
Active ingredient
certolizumab pegol, 200 MG/ML
DIN: 02465574
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE AUTOINJECTOR
Schedule: Prescription / Schedule D
Company: UCB CANADA INC
Date: 04-AUG-2017
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
- L04AB05 — CERTOLIZUMAB PEGOL (ATC/DDD)
Reference brand drug: Cimzia
